Opening of potassium channels can cause hyperpolarization and relaxation of vascular smooth muscle cells. The aim of this work was to investigate the contribution of potassium channel activation to vasorelaxation in internal thoracic artery taken from patients undergoing coronary artery bypass graft surgery. Relaxations to carbachol and sodium nitroprusside were studied in isolated rings of internal thoracic artery in the absence and presence of nitric oxide synthase inhibitors and potassium channel blockers. The nitric oxide synthase inhibitors N ω -nitro-L-arginine methyl ester and N G -monomethyl-L-arginine abolished relaxations to carbachol. Relaxations to both carbachol and sodium nitroprusside were attenuated in the presence of raised extracellular potassium and the potassium channel blockers charybdotoxin, iberiotoxin and tetraethylammonium. Neither apamin nor glibenclamide modified relaxation. ODQ (1H-[1,2,4]oxadiazolol-[4,3a] quinoxalin-1-one), an inhibitor of soluble guanylate cyclase, abolished relaxation to carbachol in rings from some but not all subjects. These results suggest that potassium channel opening may make a small contribution to endothelium-dependent vasorelaxation in internal thoracic artery. The potassium channels had characteristics consistent with those of large-conductance calcium-dependent potassium channels.
INTRODUCTION
Nitric oxide is generally considered to be the major mediator of endothelium-dependent vascular smooth muscle cell relaxation. Prostanoids may also cause vasorelaxation and there is increasing evidence that endothelium-dependent hyperpolarizing factors distinct from nitric oxide and prostanoids can cause vasorelaxation in a wide range of animal arteries [1] [2] [3] . Nitric oxide\ prostanoid-independent relaxations which are dependent on potassium channel opening have recently been reported in human vessels [4] [5] [6] . However, there is also some evidence that nitric oxide may activate potassium channels directly. Nitric-oxide-dependent activation of potassium channels and\or hyperpolarization has been Key words : hyperpolarization, internal thoracic artery, potassium channels, vasorelaxation.
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Correspondence : Dr Carlene A. Hamilton. reported to contribute to vasorelaxation in rabbit aortic smooth muscle cells [7] , guinea pig uterine artery [8] , rat pulmonary artery [9] and rabbit carotid artery [10] .
We recently demonstrated carbachol-stimulated relaxations in human radial arteries which are resistant to nitric oxide synthase and prostanoid inhibitors [11] . These relaxations appeared to be mediated by activation of calcium-dependent potassium channels. Although radial artery is being used increasingly as a conduit vessel for coronary artery bypass graft surgery, internal thoracic artery (ITA) is still the vessel of first choice. In this vessel, relaxations to acetylcholine and its analogues are abolished by nitric oxide synthase inhibitors, suggesting that relaxations in this vessel are mediated exclusively via nitric oxide [12, 13] . Normally nitric oxide produced by the endothelium diffuses to the vascular smooth muscle where it activates guanylate cyclase. This by a series of poorly defined events leads to decreases in intracellular calcium and smooth muscle relaxation. As both nitric oxide and cGMP have been reported to activate potassium channels and cause hyperpolarization, it is possible that opening of potassium channels and vascular smooth muscle cell hyperpolarization contribute to vasorelaxation in ITA.
Relaxations in response to the ATP-dependent potassium-channel-activating drugs aprikalim and levcromakalim have been reported in ITA [14, 15] . Both ATP-and Ca# + -dependent potassium channels have been implicated in hyperpolarization-dependent relaxation in animal vessels [1, 2] .
The purpose of this study was to examine the hypothesis that activation of potassium channels contributes to nitric-oxide-dependent vasorelaxation in ITA, and to investigate the type of potassium channel involved.
METHODS
Human ITA was obtained from patients undergoing coronary artery bypass graft surgery. Approval to use discarded tissues was granted by the Western Infirmary Ethical Committee, Glasgow, U.K. Human ITA was dissected as a pedicle with its venae commitantes from the thoracic wall by a no-touch technique leaving the vessels surrounded by internal thoracic fascia.
The vessel segments were immediately transferred to the laboratory. The vessels were cleaned of connective tissue and cut into 2-3-mm rings. Rings were suspended on wires in 10-ml organ chambers filled with physiological salt solution (PSS), maintained at 37 mC, and aerated with a mixture of 95 % O # \5% CO # . The rings were connected to force transducers and changes in isometric tension were recorded. The PSS (pH l 7n4p0n1) had the following composition : 130 mM NaCl, 4n7 mM KCl, 14n9 mM NaHCO
EDTA. Indomethacin, 0n02 mM, was added as contractile prostanoids have been shown to modify relaxation to carbachol in human vessels. We wanted to exclude the effects of prostanoids on vascular responses in this study.
After an initial equilibrium period of 1n5 h cumulative dose-response curves to phenylephrine (10 −) -3i 10 −& M) were constructed. Baths were washed out and tissues allowed to relax. Rings were then constricted to their individual EC &! values for phenylephrine and relaxation to carbachol (10 −) -10 −& M) or sodium nitroprusside (SNP ; 10 −* -10 −' M) was studied. We have previously shown that relaxation to carbachol is endothelium-dependent in ITA [11] whereas SNP acts directly on the smooth muscle to cause relaxation. After examining relaxation the baths were again washed out. Either the potassium concentration of the Krebs buffer was adjusted to 20 mM by increasing the molar concentration of KCl and correspondingly decreasing the concentration of NaCl, or inhibitors of nitric oxide synthase or guanylate cyclase or potassium channel blockers were added. Fifteen minutes later the rings were again constricted to the EC &! for phenylephrine. If necessary, the dose of phenylephrine was adjusted so that the tone was comparable to that previously achieved. A second dose-response curve to carbachol or SNP was then constructed. The duration of the experiment from construction of the initial dose-response curve to phenylephrine to completion was 3-4 h. Some rings, which acted as controls, had no blocking drugs added before construction of the second dose-response curves.
In a further series of experiments relaxation to the potassium opener levcromakalim (10 −( -10 −% M) was studied and the effects of raising extracellular potassium to 20 mM or of the potassium channel blocking drugs glibenclamide and charybdotoxin on this relaxation were examined.
The nitric oxide synthase inhibitors used were N Gnitro-L-arginine methyl ester (L-NAME), 200 µM, and N ω -monomethyl-L-arginine (L-NMMA), 1 mM, and the guanylate cyclase inhibitor was 1H-[1,2,4]oxadiazolol- [4,3a] quinoxalin-1-one (ODQ), 10 µM.
The following potassium channel blockers were used : tetraethylammonium (TEA) (3 mM), which is a relatively non-specific blocker of calcium-activated potassium channels ; charybdotoxin (50 nM) and iberiotoxin (100 nM), which preferentially block large-conductance calcium-activated potassium channels ; apamin (0n5 µM), which blocks small-conductance calcium-activated potassium channels ; and glibenclamide (10 µM), which blocks ATP-regulated channels.
L-NMMA was supplied by Calbiochem Ltd, Nottingham, U.K. and glibenclamide by Alexis Corporation, Nottingham, U.K. All other chemicals were obtained from Sigma-Aldrich, Poole, Dorset, U.K.
Statistical analysis
The maximum relaxation to carbachol and SNP (E max ) and the concentration of agonist required to produce 50 % relaxation (EC &! ) were calculated for each individual ring using Microsoft Excel (R) [16] . Groups contained 5-12 rings. Individual groups contained no more than two rings from any one patient. There were marked differences between patients with respect to age, plasma cholesterol levels, drug treatment and underlying disease, which could all influence relaxation to carbachol resulting in marked differences between responses in rings from different patients. To allow for such variations statistical analysis was only undertaken when it was possible to compare pre-and post-treatment values in the same rings. For comparison of pre-and post-treatment values, paired t-tests were used. All results are expressed as meanspS.E.M., P 0n05 was taken as significant, and 95 % confidence intervals (CI) are given when significance was observed.
RESULTS

Patient characteristics
Arteries from 46 patients (40 males and 6 females) were studied. The average age was 60p2 years, 30 % had a history of hypertension, 13 % were diabetic, 43 % were current or ex-smokers and the average plasma cholesterol level was 5n7p0n5 mM. The most commonly prescribed drugs were nitrates (84 %), aspirin (60 %), β-blockers (60 %), calcium antagonists (60 %) and statins (48 %).
Effect of nitric oxide synthase inhibition on relaxation to carbachol
No significant difference between the first and second dose-response curves to carbachol or SNP was observed in control rings, indicating no deterioration of the preparation with time under our experimental conditions (Table 1) . Treatment with the nitric oxide synthase blockers L-NAME and L-NMMA abolished relaxation to carbachol as shown in Figure 1 .
Effect of high extracellular potassium and potassium channel blockade on responses to carbachol
Increasing the concentration of K + in the buffer to 20 mM caused a small increase in tension ; 2p1 % of the maximum response to phenylephrine. Relaxations to carbachol were attenuated in the presence of 20 mM K + , maximum relaxation being reduced from 61p5% to 41p6% (P l 0n00001 ; 95 % CI 12n85, 26n30). However, 
EC
&!
values were not significantly altered : 0n72p0n12 µM in 4n7 mM K + and 0n79p0n12 µM in 20 mM K + PSS (Figure 2) .
None of the potassium channel blockers had any effect on the baseline tension but relaxation to carbachol was attenuated significantly in the presence of charybdotoxin, iberiotoxin and TEA (Figure 3 ). The combination of charybdotoxin and apamin had no additional effect on relaxation compared with that of charybdotoxin alone. Maximum relaxation to carbachol was reduced from 50p3 % to 36p5% (P l 0n042 ; 95 % CI 0n60, 26n95) with iberiotoxin, from 63p9 % to 56p8% (P l 0n042 ; 95 % CI 0n26, 13n80) with TEA, from 57p7 % to 39p3% (P l 0n022 ; 95 % CI 3n77, 33n66) with charybdotoxin, and from 57p6 % to 37p3 % with charybdotoxin plus apamin (P l 0n004 ; 95 % CI 9n00, 31n50). Neither apamin nor glibenclamide attenuated relaxations to carbachol, maximum relaxation being 51p3 % and 59p3 % in the absence and presence of apamin and 41p2 % and 42p8 % in the absence and presence of glibenclamide. 
Effect of high extracellular potassium and potassium channel blockade on relaxation to SNP
Increasing the extracellular potassium concentration to 20 mM also inhibited relaxation to SNP, although the attenuation of response was smaller than that observed with carbachol ( Figure 4) . Maximum relaxation was reduced from 104 % to 92p5 % in the presence of 20 mM K + (P l 0n013 ; 95 % CI 2n93, 19n07). Similarly TEA, charybdotoxin and iberiotoxin but not apamin or glibenclamide decreased relaxation. However, as with 20 mM K + , the effects were smaller than those observed on carbachol-induced relaxation. A comparison of the attenuation of relaxation to carbachol and SNP by the potassium channel blockers is shown in Table 1 . No significant effects on EC &! values for relaxation were observed. Potassium channels and vasorelaxation
Figure 5 Effect of ODQ treatment on relaxation to carbachol
Top, typical recording from a vessel in which ODQ abolishes relaxation ; bottom, typical recording from a vessel in which relaxation to carbachol is still observed after treatment with ODQ.
Effect of ODQ treatment on relaxation to carbachol
In rings from some patients ODQ, 10 µM, completely abolished relaxation to carbachol. In vessels from other subjects a small but definite relaxation was still present after treatment with ODQ ( Figure 5 ). Overall maximum relaxation was reduced from 59p7 % to 13p4 %. Increasing the concentration of ODQ to 20 µM had no additional effect on relaxations to carbachol in these rings. When two rings from the same patient were examined, both behaved in the same manner. In this series of experiments 15 rings from 11 patients were examined. Rings from seven patients failed to relax after treatment with ODQ. In the remaining four patients the maximum relaxation after treatment was 23p4 %. The initial relaxations in rings which showed resistance to ODQ treatment were significantly greater than in those rings in which ODQ treatment completely abolished relaxation, maximum relaxation being 72p8 % (range 101-48 %) and 45p5 % (range 72-32 %) respectively. No significant relaxation to SNP was observed in any of the rings treated with ODQ, relaxation being reduced from 118p6 % to 9p2%.
Effects of potassium channel blockers on relaxation to levcromakalim
Levcromakalim caused a dose-dependent relaxation of ITA over the concentration range studied ; however, there was still a linear increase in relaxation with the highest dose administered (10 −% M) thus maximal relaxation could not be calculated for this agonist. Increasing the concentration of K + in the buffer to 20 mM caused a large reduction in relaxation to levcromakalim 10 −% M, from 67p8 % to 35p5% (P l 0n0053 ; 95 % CI 17n1, 66n2). Glibenclamide (10 µM) reduced relaxation to 10 −% M levcromakalim from 62p4 % to 35p5% (P l 0n0052 ; 95 % CI 12n06, 40n94). In contrast, charybdotoxin (50 nM) had no significant effect on relaxation to levcromakalim 10 −% M, with relaxations of 60p6 % and 59p9 % in the absence and presence of charybdotoxin respectively.
DISCUSSION
In this study in human ITA we observed attenuation of vasorelaxation to carbachol and SNP in the presence of 20 mM K + which suggests that opening of potassium channels and vascular smooth muscle hyperpolarization may contribute to these relaxations. Nitric oxide synthase blockers are able to abolish relaxations to carbachol in ITA [12, 13] thus it would appear that these effects are mediated via nitric oxide. Although potassium channel activation and hyperpolarization of vascular smooth muscle in response to nitric oxide has been reported in arteries from a number of species, this is the first indication that it may also occur in human arteries.
The studies with selective potassium channel blockers suggest that large-conductance calcium-dependent potassium channels are involved. Relaxations were inhibited by TEA, a relatively non-specific potassium channel blocker, and by charybdotoxin and iberiotoxin, both of which can block large-conductance potassium channels. Apamin and glibenclamide, which block smallconductance calcium-dependent potassium channels and ATP-dependent potassium channels respectively, caused no attenuation of relaxation.
These results are in contrast to those obtained when relaxation to the potassium channel activator levcromakalim was examined in ITA, and to those obtained when studying nitric oxide\prostanoid-independent relaxation to carbachol in radial arteries. In the former case, relaxations to levcromakalim were greatly attenuated in the presence of raised extracellular potassium or glibenclamide and unchanged in the presence of charybdotoxin. In radial arteries, iberiotoxin and TEA had little effect on relaxation to carbachol while the combination of charybdotoxin plus apamin caused a significantly greater attenuation of relaxation than charybdotoxin alone. Thus the effects of the potassium channel blockers are both agonist and tissue specific. The responses to levcromakalim described in this paper are similar to those reported by others [14, 15] for aprikalim and levcromakalim respectively in ITA.
Relaxations to the nitric oxide donor SNP were also attenuated in the presence of high extracellular potassium. Treatment with TEA, charybdotoxin and iberiotoxin also caused decreased relaxation to SNP. However, although relaxation to SNP was greater than that to carbachol, raising the extracellular potassium concentration to 20 mM and addition of potassium channel blockers caused less attenuation of responses to SNP than to carbachol. This is surprising if opening of potassium channels was mediated via nitric oxide. However, relaxation to carbachol and SNP are primarily dependent on activation of guanylate cyclase and synthesis of cGMP which in turn leads to a decrease in the calcium concentration within the cell. The large relaxations observed in the presence of SNP (100 % plus) would be consequent on greatly reduced intracellular calcium which may reduce the activity of calciumdependent potassium channels and thus their contribution to relaxation. Another possibility is that the vasodilator response to carbachol involves release of mediators in addition to nitric oxide that open potassium channels. However, if this were the explanation, one might expect to observe significant relaxation in the presence of nitric oxide synthase inhibitors. Yet another explanation would be that activation of potassium channels on the endothelium contributed to relaxation to carbachol but not SNP. Relaxation to carbachol is dependent on the presence of the endothelium in ITA [13] whereas SNP acts directly on vascular smooth muscle. In support of this hypothesis it has recently been proposed that endothelium-derived hyperpolarizing factor is potassium which activates channels on the endothelium [17] .
Direct activation of potassium channels by nitric oxide has been demonstrated in rabbit aortic smooth muscle cells [7] and rabbit carotid artery [10] . Other groups have shown that nitric oxide activation of potassium channels occurs via cGMP [9, 18] whereas Koh et al. [19] suggest that in canine colonic smooth muscle, hyperpolarization in response to nitric oxide may be activated by dual pathways involving direct activation by nitric oxide-and cGMP-mediated mechanisms. In an attempt to determine whether activation of potassium channels on vascular smooth muscle in ITA is mediated directly by nitric oxide or via cGMP, the selective inhibitor of soluble guanylate cyclase, ODQ, was used. However, our results were inconclusive. Although in the majority of patients ODQ abolished relaxation to carbachol and SNP significant relaxation to carbachol persisted in rings from four patients. In these rings neither increasing the dose of ODQ nor the time of incubation in the presence of ODQ resulted in any additional attenuation of relaxation.
The role of potassium channels in mediating vasorelaxation may be modified in pathological conditions. Najibi et al. [20] reported an enhanced role for potassium channels in relaxations to acetylcholine in hypercholesterolaemic rabbit carotid artery. Alterations in the contribution of potassium channel activation to endothelium-dependent relaxation have also been observed in mesenteric arteries from rats with streptozotocin-induced diabetes [21] and in the mesenteric artery of spontaneously hypertensive rats [22] . The majority of patients donating vessels for the present study had multiple risk factors for atherosclerotic disease. In addition, most patients were on multiple drug therapy before surgery. Chronic treatment with some of these drugs, in particular nitrates and the calcium channel blockers, could affect the vasodilator responses examined in this study. The effect of chronic nitrate treatment in vivo on vascular responses in vitro is uncertain. Du et al. [23] reported that treatment of patients before coronary artery bypass graft surgery with glyceryl trinitrate modified responses to SNP but not acetylcholine in isolated mammary arteries in vitro. However, Schneider and colleagues [24] found that chronic nitrate pretreatment of patients did not influence relaxation in isolated segments of saphenous vein. The results from this study may not be exactly comparable with those obtained using vessels from healthy young subjects. However, conduit arteries from these subjects are not readily obtainable. Studies of vessels from patients with overt vascular disease may have particular clinical relevance. This is the first report suggesting that nitric-oxidedependent activation of potassium channels may occur in human vessels. Nitric-oxide-independent potassium channel activation and\or vascular smooth muscle hyperpolarization has been demonstrated recently in several human arteries including radial artery [11] , gastroepiploic arteries [5] , omental arteries [6] , coronary arteries [4, 25] and some pial arteries [3] . It has been suggested that hyperpolarization makes a greater contribution to vasorelaxation in small resistance vessels than in large arteries [5, 26, 27] . With the exception of radial arteries these vessels are of smaller diameter than ITA. In gastroepiploic arteries, hyperpolarization was abolished by tetrabutylammonium and attenuated by charybdotoxin but not iberiotoxin, whereas in radial arteries nitric-oxideindependent relaxations were preferentially inhibited by the combination of charybdotoxin and apamin. In the studies reported here in ITA, relaxation was similarly inhibited by TEA, charybdotoxin and iberiotoxin. Thus, although there is increasing evidence for potassium channel activation contributing to vasorelaxation in human arteries, the channels involved and the mechanisms leading to activation may differ between vessels.
The presence of multiple endothelium-dependent factors contributing to vasorelaxation may help maintain vascular tone in disease states. Knowledge of the factors regulating endothelium-dependent vasodilatation in different vessels may be important in optimizing treatment in vascular disease.
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